Largest pharmaceutical companies by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
AbbVie leads the 35 pharmaceutical companies ranked by total debt, at DKK 459.6B, ahead of Pfizer (DKK 441.2B) and Merck & Co (DKK 335.7B). Figures as of 18 Nov 2026, 20:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- First
- AbbVieDKK 459.6B
- Median
- DKK 35.9B
- Combined market value
- DKK 34.55T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | DKK 459.6B | DKK 3.45T | DKK 1,952.11 | 2.09% down | 26% up | ||
| 2 | PfizerPFE · Health Care | DKK 441.2B | DKK 1.09T | DKK 191.57 | 1.18% down | 14% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 335.7B | DKK 2.32T | DKK 942.10 | 3.49% down | 51% up | ||
| 4 | Johnson & JohnsonJNJ · Health Care | DKK 326.4B | DKK 4.49T | DKK 1,864.55 | 1.75% down | 38% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | DKK 307.2B | DKK 834.5B | DKK 408.27 | 2.27% down | 34% up | ||
| 6 | Eli LillyLLY · Health Care | DKK 289.4B | DKK 8.42T | DKK 9,450.70 | 1.95% down | 35% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | DKK 208.2B | DKK 463B | DKK 144.93 | 1.64% down | 54% up | ||
| 8 | AstraZenecaAZN · Health Care | DKK 201.7B | DKK 1.89T | DKK 1,219.63 | 1.73% down | 2% up | ||
| 9 | NovartisNVS · Health Care | DKK 195.6B | DKK 2T | DKK 1,057.61 | 2.39% down | 25% up | ||
| 10 | SanofiSNY · Health Care | DKK 141.3B | DKK 771.6B | DKK 321.32 | 0.72% down | 4% down | ||
| 11 | Novo NordiskNVO · Health Care | DKK 132.3B | DKK 1.18T | DKK 268.72 | 3.03% down | 17% down | ||
| 12 | GSKGSK · Health Care | DKK 130.6B | DKK 665.2B | DKK 331.87 | 1.02% down | 6% up | ||
| 13 | ViatrisVTRS · Health Care | DKK 98.1B | DKK 159.3B | DKK 138.97 | 0.20% down | 96% up | ||
| 14 | Abbott LaboratoriesABT · Health Care | DKK 88B | DKK 1.24T | DKK 715.05 | 0.29% up | 17% down | ||
| 15 | ZoetisZTS · Health Care | DKK 61.6B | DKK 239.4B | DKK 589.25 | 3.67% up | 29% down | ||
| 16 | Royalty PharmaRPRX · Health Care | DKK 60.9B | DKK 270B | DKK 469.58 | 0.41% up | 78% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 36.5B | DKK 107.6B | DKK 1,676.52 | 2.29% up | 37% up | ||
| 18 | GenmabGMAB · Health Care | DKK 35.9B | DKK 215B | DKK 348.69 | 1.44% down | 70% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | DKK 27.4B | DKK 91.5B | DKK 183.13 | 4.04% up | 20% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | DKK 17.5B | DKK 51.9B | DKK 148.91 | 3.55% up | 83% up | ||
| 21 | BridgeBio PharmaBBIO · Health Care | DKK 13.7B | DKK 103.3B | DKK 530.15 | 1.38% up | 17% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | DKK 13.5B | DKK 667.3B | DKK 6,451.01 | 1.08% down | 36% up | ||
| 23 | Ionis PharmaceuticalsIONS · Health Care | DKK 12.3B | DKK 31.6B | DKK 189.56 | 3.26% up | 64% down | ||
| 24 | BeOne MedicinesONC · Health Care | DKK 7B | DKK 314.3B | DKK 2,751.80 | 2.21% down | 17% up | ||
| 25 | Ascendis PharmaASND · Health Care | DKK 5.4B | DKK 121B | DKK 1,845.25 | 0.07% down | 28% up | ||
| 26 | InsmedINSM · Health Care | DKK 3.7B | DKK 179.1B | DKK 816.20 | 1.63% down | 40% down | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 2.3B | DKK 62.7B | DKK 2,698.01 | 6.10% down | 24% down | ||
| 28 | Legend BiotechLEGN · Health Care | DKK 2.2B | DKK 21.4B | DKK 110.58 | 0.81% up | 42% down | ||
| 29 | CytokineticsCYTK · Health Care | DKK 2B | DKK 48.9B | DKK 351.31 | 0.11% down | 20% down | ||
| 30 | TG TherapeuticsTGTX · Health Care | DKK 1.7B | DKK 68.1B | DKK 450.35 | 5.47% up | 107% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | DKK 1.5B | DKK 33.3B | DKK 191.40 | 0.93% up | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 1.3B | DKK 85.2B | DKK 102.24 | 1.52% up | 5% up | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | DKK 1.3B | DKK 48B | DKK 912.21 | 1.46% down | 7% down | ||
| 34 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 736.6M | DKK 56.1B | DKK 809.22 | 1.92% up | 13% up | ||
| 35 | Definium TherapeuticsDFTX · Health Care | DKK 276.3M | DKK 27B | DKK 197.22 | 1.41% down | 169% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8090 DKK). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by total debt?
AbbVie (DKK 459.6B), Pfizer (DKK 441.2B) and Merck & Co (DKK 335.7B) are the top three of the 35 pharmaceutical companies ranked by total debt as of 18 Nov 2026, 20:27 UTC.
How many pharmaceutical companies are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 35 pharmaceutical companies ranked by total debt have a combined market value of DKK 34.55T as of 18 Nov 2026, 20:27 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.